Device Authority targets enterprise IoT security demand through Xalient partnership

Tern plc

Device Authority has partnered with Xalient to strengthen IoT security for enterprise customers, with its KeyScaler platform being added to Xalient’s managed cybersecurity services.

The partnership is designed to help large organisations secure connected devices more effectively, particularly where IoT and operational technology assets are spread across complex environments. Device Authority is being positioned inside a managed enterprise security offering, giving it a clearer route to customers that need scalable device identity and access management.

Xalient provides identity-led cybersecurity and managed security services. By integrating Device Authority’s KeyScaler technology, it will be able to offer automated protection for connected devices across their full lifecycle. This includes device onboarding, credential management, certificate rotation, access control and decommissioning.

These are practical security functions for enterprises. As more organisations connect equipment, sensors, machines and operational systems, the number of devices that need to be identified, authenticated and managed continues to grow. Manual processes are difficult to scale and can increase risk. Automated device identity management helps reduce gaps in visibility and control.

The partnership focuses on sectors where secure connected infrastructure matters. Energy and utilities, manufacturing, healthcare and critical infrastructure often run large device networks where downtime, unauthorised access or weak credential management can create operational and compliance risks.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Talking Medicines highlights strategic value of patient journey intelligence

Patient journey intelligence can help healthcare organisations identify care barriers and design more responsive pathways around real patient experiences.

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Search